Pharmacological characterization of a new highly potent B2 receptor antagonist (HOE 140: D-Arg-[Hyp3,Thi5,D-Tic7,Qic8]bradykinin).
N E Rhaleb, N Rouissi, D Jukic, D Regoli, S Henke, G Breipohl, J Knolle
Index: Eur. J. Pharmacol. 210(2) , 115-20, (1992)
Full Text: HTML
Abstract
HOE 140 (D-Arg-[Hyp3,Thi5,D-Tic7,Oic8]bradykinin), a new B2 antagonist, was compared to R-493 (D-Arg[Hyp3-D-Phe7,Leu8]bradykinin) with respect to inhibition of the responses of seven isolated smooth muscle preparations to bradykinin. R-493 was found to exert: (a) high antagonistic activity on the rabbit jugular vein (pA2 of 8.86), (b) moderate activity on the rabbit aorta, guinea-pig ileum, hamster urinary bladder and human urinary bladder (pA2 of 5.76, 6.77, 7.16 and 7.15, respectively) and (c) a stimulatory effect on the guinea-pig trachea. On the other hand, HOE 140 showed identical apparent affinities (8.36-9.12) on all preparations except the rabbit aorta where it was inactive and the guinea-pig trachea where the compound was an antagonist (pA2: 7.42) without agonistic effect. HOE 140 is specific and selective for B2 receptors since it was inactive against angiotensin II, substance P, neurokinin A, desArg9-bradykinin, noradrenaline or acetylcholine in the various preparations. R-493 inhibited the contractile effects of bradykinin competitively, while HOE 140 was not competitive even at low concentrations (7.7 x 10(-9) M). These results demonstrate that HOE 140 is a potent B2 antagonist with high affinity, specific for kinin receptors and selective for the B2 receptor type, but is non-competitive. HOE 140 is the first bradykinin receptor antagonist that acts as such on the guinea-pig trachea without showing any agonistic activity.
Related Compounds
Related Articles:
New highly potent bradykinin B2 receptor antagonists.
1991-09-01
[Agents Actions 34 , 138-141, (1991)]
Non-selectivity of new bradykinin antagonists for B1 receptors.
1992-01-01
[Life Sci. 51 , PL 125, (1992)]
1992-05-01
[J. Med. Chem. 35 , 1563, (1992)]
Pharmacological evidence for a single bradykinin B2 receptor in the guinea-pig.
1995-10-01
[Br. J. Pharmacol. 116(3) , 2106-12, (1995)]